These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17720098)

  • 1. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women.
    Wu WH; Lu SC; Wang TF; Jou HJ; Wang TA
    Eur J Clin Nutr; 2006 Mar; 60(3):386-92. PubMed ID: 16278686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
    J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial.
    Hopkins MH; Fedirko V; Jones DP; Terry PD; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):850-8. PubMed ID: 20200432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
    Bowden RG; Wilson RL; Deike E; Gentile M
    Nutr Clin Pract; 2009; 24(4):508-12. PubMed ID: 19461006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
    Begum R; Belury MA; Burgess JR; Peck LW
    J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.
    Nascimento MM; Suliman ME; Murayama Y; Nihi M; Hayashi SY; Stenvinkel P; Riella MC; Lindholm B
    J Ren Nutr; 2006 Apr; 16(2):119-24. PubMed ID: 16567267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
    Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
    J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients.
    Rashidi AA; Salehi M; Piroozmand A; Sagheb MM
    J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
    Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is systemic inflammation of hemodialysis patients improved with the use of enalapril? Results of a randomized, double-blinded, placebo-controlled clinical trial.
    Ordaz-Medina SM; González-Plascencia J; Martín del Campo F; Rojas-Campos E; Montañez-Fernández JL; Espinoza-Gómez F; Cueto-Manzano AM
    ASAIO J; 2010; 56(1):37-41. PubMed ID: 20051840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
    Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.